Efficacy and safety of olanzapine/fluoxetine combination in the treatment of treatment-resistant depression: a meta-analysis of randomized controlled trials

BACKGROUND: Whether olanzapine/fluoxetine combination (OFC) is superior to olanzapine or fluoxetine monotherapy in patients with treatment-resistant depression (TRD) remains controversial. Thus, we conducted this meta-analysis of randomized controlled trials (RCTs) to compare the efficacy and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Luan, Shuxin, Wan, Hongquan, Wang, Shijun, Li, He, Zhang, Baogang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338977/
https://www.ncbi.nlm.nih.gov/pubmed/28280343
http://dx.doi.org/10.2147/NDT.S127453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338977/
https://www.ncbi.nlm.nih.gov/pubmed/28280343
http://dx.doi.org/10.2147/NDT.S127453

Ejemplares similares